ERNA
Eterna Therapeutics IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$13.98M
P/E Ratio
0.01
EPS
$1214.25
Beta
1.89
52W High
$91.54
52W Low
$3.18
50-Day MA
$6.61
200-Day MA
$23.54
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Eterna Therapeutics Inc
Brooklyn ImmunoTherapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to developing therapies to treat cancer patients. The company is headquartered in Brooklyn, New York.
Fundamentals
| Revenue (TTM) | 1,000 |
| Gross Profit (TTM) | 1,000 |
| EBITDA | $-10.08M |
| Operating Margin | 0.00% |
| Return on Equity | -2506.00% |
| Return on Assets | -81.20% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.31 |
| Price-to-Book | 2.03 |
| Price-to-Sales (TTM) | 1275.37 |
| EV/Revenue | 4581.99 |
| EV/EBITDA | -0.29 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -94.10% |
| Shares Outstanding | $1.17M |
| Float | 818,090 |
| % Insiders | 41.78% |
| % Institutions | 10.16% |
Historical Volatility
HV 10-Day
134.14%
HV 20-Day
106.70%
HV 30-Day
98.68%
HV 60-Day
115.01%
HV Rank
—
Volatility is currently expanding
More HEALTHCARE Stocks
Data last updated: 5/25/2026